(GMAB) Genmab - Performance -28.8% in 12m
Compare GMAB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-40.49%
#61 in Group
Rel. Strength
21.22%
#6285 in Universe
Total Return 12m
-28.82%
#79 in Group
Total Return 5y
-15.01%
#44 in Group
P/E 11.1
50th Percentile in Group
P/E Forward 11.3
44th Percentile in Group
PEG 1.08
83th Percentile in Group
FCF Yield 9.87%
98th Percentile in Group
12m Total Return: GMAB (-28.8%) vs XBI (-5.4%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
| HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
| AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
| LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
| ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
| BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: GMAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GMAB
| Total Return (including Dividends) | GMAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 7.12% | 5.55% | -0.45% |
| 3 Months | 0.39% | -9.75% | -6.29% |
| 12 Months | -28.82% | -5.39% | 13.04% |
| 5 Years | -15.01% | -13.20% | 111.82% |
| Trend Score (consistency of price movement) | GMAB | XBI | S&P 500 |
| 1 Month | 63.3% | 70% | 47.5% |
| 3 Months | -63.4% | -88.1% | -87.3% |
| 12 Months | -89.1% | -44.4% | 54.3% |
| 5 Years | -45.7% | -53.6% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #102 | 1.49% | 7.60% |
| 3 Month | #55 | 11.2% | 7.14% |
| 12 Month | #80 | -24.8% | -37.0% |
| 5 Years | #47 | -2.08% | -59.9% |
FAQs
Does GMAB Genmab outperforms the market?
No,
over the last 12 months GMAB made -28.82%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months GMAB made 0.39%, while XBI made -9.75%.
Over the last 3 months GMAB made 0.39%, while XBI made -9.75%.
Performance Comparison GMAB vs Indeces and Sectors
GMAB vs. Indices GMAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.25% | 7.57% | -8.07% | -41.9% |
| US NASDAQ 100 | QQQ | 1.33% | 5.22% | -8.78% | -43.8% |
| US Dow Jones Industrial 30 | DIA | 2.79% | 9.97% | -7.31% | -38.1% |
| German DAX 40 | DAX | 2.61% | 7.34% | -26.2% | -53.8% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.90% | 10.3% | -4.37% | -33.8% |
| Hongkong Hang Seng | HSI | 2.65% | 8.64% | -8.60% | -41.8% |
| India NIFTY 50 | INDA | 4.77% | 2.24% | -7.95% | -31.7% |
| Brasil Bovespa | EWZ | 3.88% | 4.29% | -13.8% | -22.1% |
GMAB vs. Sectors GMAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.10% | 7.72% | -14.1% | -52.3% |
| Consumer Discretionary | XLY | 2.22% | 7.71% | -9.24% | -43.5% |
| Consumer Staples | XLP | 4.31% | 7.94% | -12.2% | -39.8% |
| Energy | XLE | 6.51% | 21.2% | -2.93% | -19.5% |
| Financial | XLF | 3.36% | 9.13% | -15.0% | -51.5% |
| Health Care | XLV | 4.95% | 11.8% | -2.91% | -27.6% |
| Industrial | XLI | 1.93% | 6.82% | -9.11% | -39.5% |
| Materials | XLB | 4.06% | 10.3% | -0.23% | -24.4% |
| Real Estate | XLRE | 2.36% | 8.22% | -8.23% | -47.2% |
| Technology | XLK | 0.69% | 4.69% | -5.12% | -39.3% |
| Utilities | XLU | 3.53% | 7.02% | -12.5% | -49.6% |
| Aerospace & Defense | XAR | 1.22% | 0.14% | -22.0% | -56.3% |
| Biotech | XBI | 2.41% | 1.57% | 7.24% | -23.4% |
| Homebuilder | XHB | 3.52% | 9.20% | 6.89% | -22.7% |
| Retail | XRT | 3.49% | 8.28% | -2.11% | -27.3% |